SUREFIRE RESOURCES NL — Interim / Quarterly Report 2005

Oct 13, 2005

$Rule 4.7B$

Appendix 4C

Three Month report for entities admitted on the basis of commitments

Introduced 31/3/2000. Amended 30/9/2001

Name of entity

Genesis Biomedical Limited

ABN

48 083 274 024

Three Month period ending September 2005

Consolidated statement of cash flows

Cash flows related to operating activities		Current month(September 2005)$A'000	Year to date$(3 \text{ month})$$A'000
1.1	Receipts from customers
1.2	Payments for(a) staff costs(b) advertising and marketing(c) research and development(d) leased assets	(0)	(23)
	(e) other working capital	(34)	(181)
1.3	Dividends received
1.4	Interest and other items of a similar naturereceived	$\theta$	6
1.51.6	Interest and other costs of finance paidIncome taxes paid
1.7	Other – Provision of $2nd$ tranche loan funding toManawatu Biotech Investments Limited pursuantto Loan Facility Agreement announced 18 th July2005	(32)	(148)
	Net operating cash flows	(66)	(346)

+ See chapter 19 for defined terms.

		Current month(September)$A'000	Year to date$(3$ months)$A'000
1.8	Net operating cash flows (carried forward)	(66)	(346)
	Cash flows related to investing activities
1.9	Payment for acquisition of:
	(a) businesses (item 5)
	(b) equity investments(c) intellectual property
	(d) physical non-current assets
	(e) other non-current assets
1.10	Proceeds from disposal of:
	(a) businesses (item $5$ )
	(b) equity investments
	(c) intellectual property
	(d) physical non-current assets(e) other non-current assets
1.11	Loans to other entities
1.12	Loans repaid by other entities
1.13	Other (provide details if material)
	Net investing cash flows	0	$\theta$
1.14	Total operating and investing cash flows	(66)	(346)
1.15	Cash flows related to financing activitiesProceeds from issues of shares, options, etc.
1.16	Proceeds from sale of forfeited shares	0	$\theta$
1.17	Proceeds from borrowings
1.18	Repayment of borrowings
1.19	Dividends paid
1.20	Part refund of property lease security deposit
	Net financing cash flows	0	$\theta$
	Net increase (decrease) in cash held	(66)	(346)
1.21	Cash at beginning of month/year to date	784	1,064
1.22	Exchange rate adjustments to item 1.20
1.23	Cash at end of month/YTD	718	$718,$

* The Company also had approximately $132,000 in security deposits which have not been included in the cash at the end of the periods.

+ See chapter 19 for defined terms.

Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities

		Current month
		(September)
		$A'000
1.24	Aggregate amount of payments to the parties included in item 1.2	21
1.25	Aggregate amount of loans to the parties included in item 1.11

1.26 Explanation necessary for an understanding of the transactions Being Consulting Fees relating to Dr Robert Gilmour $21k.

Non-cash financing and investing activities

• $2.1$ Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows
• $2.2$ Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Financing facilities available

Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).

		Amount available$A'000	Amount used$A'000
3.1	Loan facilities
-3.2	Credit standby arrangements

+ See chapter 19 for defined terms.

Reconciliation of cash

Reconciliation of cash at the end of the quarter (asshown in the consolidated statement of cash flows) tothe related items in the accounts is as follows.		Current$A'000	Previous period$A'000
4.1	Cash on hand and at hank	10	76
4.2	Deposits at call	708	708
4.3	Bank overdraft.
4.4	Other (provide details)
	Total: cash at end of quarter (item 1.22)	718	784

Acquisitions and disposals of business entities

		Acquisitions(Item 1.9(a))	Disposals(Item $1.10(a)$ )
5.1	Name of entity
5.2	Place of incorporationor registration
5.3	Consideration foracquisition or disposal
54	Total net assets
5.5	Nature of business

Compliance statement

• $\mathbf{1}$ This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.
• This statement does give a true and fair view of the matters disclosed. $\overline{2}$

Sign here:

Date: .... 14/10/05..................................

Print name: ..Shane Hartwig....................................

+ See chapter 19 for defined terms.

Notes

• $11$ The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.
• $\overline{2}$ . The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.
  • reconciliation of eash flows arising from operating activities to $6.2$ $\bullet$ operating profit or loss
  • $9.2$ - itemised disclosure relating to acquisitions
  • itemised disclosure relating to disposals 9.4
  • $12.1(a)$ policy for classification of cash items $\bullet$
  • disclosure of restrictions on use of cash $12.3$ $\bullet$
  • comparative information 13.1 $\bullet$
• $3.$ Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

+ See chapter 19 for defined terms.